查詢結果分析
來源資料
相關文獻
- 肺鱗狀上皮細胞癌皮膚轉移:病例報告及文獻回顧
- Cutaneous Metastasis of Lung Cancer: An Ominous Prognostic Sign
- Lung Cancer with Skin Metastasis: Report of 12 Cases
- Lung Cancer in Pregnancy: Report of Two Cases
- Ifosfamide-Based Chemotherapy for Previously Treated Lung Cancer Patients
- 雙側卵巢Krukenberg腫瘤之皮膚轉移
- 化學防癌與肺癌
- 非小細胞肺癌術前輔助性化學治療的經驗
- Outcome of Patients with Lung Cancer Treated with Mechanical Ventilation for Respiratory Failure
- 不吸菸婦女肺癌研究
頁籤選單縮合
題 名 | Cutaneous Metastasis of Lung Cancer: An Ominous Prognostic Sign=肺癌合併皮膚轉移:惡性預後之徵兆 |
---|---|
作 者 | 彭殿王; 陳重華; 李毓芹; 彭瑞鵬; | 書刊名 | 中華醫學雜誌 |
卷 期 | 57:5 1996.05[民85.05] |
頁 次 | 頁343-347 |
分類號 | 415.468 |
關鍵詞 | 肺癌; 皮膚轉移; Bronchogenic carcinoma; Cutaneous metastasis; |
語 文 | 英文(English) |
中文摘要 | 背景 原發性肺癌合併皮膚轉移相對於轉移至其它器官是非常少兒 的,它們不具有單一或特殊的疾病表徵,而且往往被誤認為許多良性的病灶, 其診斷結果及預後是極端不同。因此我們對於肺癌轉移至皮膚的病例加以收集, 在這份研究中,我們回溯性的分析63個肺癌合併皮膚轉移的病例,並探討其臨 床的表徵和存活率。 方法 從1984年1月至1994年5月,我們從台北榮民總醫院癌病治療中心處 收集5539例肺癌,並做回溯性分析,確認合併皮膚轉移者為72例,其中9例 因臨床記載資料不完整而被排除。 結果 A群病人佔多數(48/63,72.2%),這些病人先發現肺癌而後出現皮膚轉移 的病灶,皮膚病灶較肺部病灶先發現者為B群有15位病人(15/63,23.8%)。臨 床上皮膚轉移有4種主要表徵:孤立性結節、成簇形結節、紅斑性丘疹和凸起 形腫塊。孤立性結節是最常出現的形態(41/63,65.1%),表面積大小於0.5x0.5公 分至25x15公分,胸部和腹部是最常見的轉移部位,其它罕見的轉移病灶可出 現在陰囊、口唇、會陰等地方,腺癌是轉移至皮膚最主要的細胞型態,從確定 皮膚轉移至死亡,A群與B群的存活期並沒有差別(p>0.05),診斷出現皮膚轉移 至死亡的存活期從三個星期到十四個月不等,二十二位病人(35%)存活期少於一 個月,平均存活期是三個月。 結論 在本研究中發現,皮膚轉移是非常惡性的徵兆,意味著不良的預後和即 將面臨死亡,內科醫師應對其臨床表徵及其預後意義有所警覺。 |
英文摘要 | Background. Cutaneous metastases in primary lung cancer rarely occurs in comparison with other organ involvement. Because of the absence of any uniform or pathognomic feature, they are often mistaken as a variety of benign lesions so that the outcome is extremely different. In this study, sixty-three cases of lung cancer with cutaneous metastases were retrospectively analyzed to determine the clinical pictures and length of survival. Methods. Retrospective analyses were performed for 5539 cases of proven lung cancer collected at the Cancer Treatment Center in Veterans General Hospital- Taipei during the period from January 1984 to May 1994. Seventy-two cases were documented cutaneous metastases. Nine of them were excluded due to inadequate medical records on clinical course. Results. Group A included the majority (48/63, 76.2%) of patients who had primary lung cancer with subsequent cutaneous metastases. The other 15 patients with cutaneous metastases as the initial presentations were classified as group B (15/63, 23.8%). There were four major clinical presentations: solitary nodules, cluster of nodules, erythematous papule and bulging mass. Solitary nodule was the most frequent pattern (41/63, 65.1%), ranging in size from 0.5 x 0.5 cm to 25 x 15 cm in surface area. The chest wall and abdominal wall were the regions most likely to develop cutaneous metastases. Metastatic lesions were occasionally found over the scrotum, lip and perianal region. Adenocarcinoma was the predominant cell type of cutaneous spread (25/63, 39.7%). The survival after diagnosis of cutaneous metastasis ranged from 3 weeks to 14 months, without significant difference between two groups of patients. Twenty-two patients (35%) survived no more than one month. The median survival was 3 months. Conclusions. Cutaneous metastasis, as observed in our study, is an ominous sign indicating a poor prognosis with imminent death. Physicians should be alert to its characteristics and prognostic significance. |
本系統中英文摘要資訊取自各篇刊載內容。